Skip to content

Novavax NVAX Net margin

Net margin at other companies

Moderna logo
ModernaMRNA
-143.6%+80.2pp
Roivant Sciences logo
Roivant SciencesROIV
-6,079.9%-6,193pp
Merck & Co. logo
Merck & Co.MRK
13.6%-13.7pp
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
-508.5%-254pp
ALN
Alnylam PharmaceuticalsALNY
11.7%+8.0pp
Gilead Sciences logo
Gilead SciencesGILD
31%+10.2pp

Other financials

Income statement

See full
Revenue$139.5M-79.1%
Gross profit$108.8M-83.3%
Operating income-$15.4M-103%
Net income-$9.5M-102%
EPS (diluted)-$0.06-102%

Balance sheet

See full
Cash & equivalents$228.4M-13.3%
Total debt$295.1M+404%
Total equity-$144.8M-91.4%
Total assets$1.0B-19.3%

Cash flow

See full
Operating cash flow-$32.4M+82.5%
CapEx$1.3M-20.4%
Free cash flow-$33.7M+82.0%

Valuation

See full
Market cap$1.46B+41.0%
Enterprise value$1.53B+83.6%
P/S2.5×+1.6×

Profitability

See full
Gross margin85%-2.5pp
Operating margin-13.1%-45.9pp
FCF margin-58.9%-61.4pp

Returns & leverage

See full
Return on equity-238.6%
Debt / equity1.5×
Current ratio2.5×+0.4×

Where this comes from

Calculated from Novavax’s reported figures.

Based on trailing twelve months.

The official record: Novavax’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Novavax's net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Novavax's net margin?
Novavax (NVAX) reported net margin of -14.7% in Q1 2026.
How has Novavax's net margin changed year-over-year?
Novavax's net margin decreased by 138.6% year-over-year, from 38.1% to -14.7%.
What is the long-term trend for Novavax's net margin?
Over 5 years (2020 to 2025), Novavax's net margin has grown at a -14.9% compound annual growth rate (CAGR), from -87.9% to 39.2%.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.